PReS-FINAL-2140: Neutropenia with Tocilizumab (TCZ) treatment is not associated with increased infection risk in patients with systemic juvenile idiopathic arthritis (SJIA)

被引：0
|
作者：
F De Benedetti
HI Brunner
E Baildam
R Burgos-Vargas
G Horneff
HI Huppertz
K Minden
BL Myones
K Onel
J Wang
K Bharucha
D Lovell
A Martini
N Ruperto
机构：
[1] IRCCS Ospedale Ped Bambino Gesú,
[2] PRCSG,undefined
[3] PRINTO,undefined
[4] Roche,undefined
[5] Genentech,undefined
来源：
Pediatric Rheumatology | / 11卷 / Suppl 2期
关键词：
Placebo; Methotrexate; Glucocorticoid; Neutropenia; Neutrophil Count;
D O I：
10.1186/1546-0096-11-S2-P152
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Neutropenia With Tocilizumab Treatment Is Not Associated With Increased Infection Risk in Patients With Systemic Juvenile Idiopathic Arthritis
    De Benedetti, Fabrizio
    Ruperto, Nicolino
    Baildam, Eileen
    Burgos-Vargas, Ruben
    Horneff, Gerd
    Huppertz, Hans Iko
    Minden, Kirsten
    Myones, Barry L.
    Onel, Karen
    Wang, Jianmei
    Bharucha, Kamal N.
    Lovell, Daniel J.
    Martini, Alberto
    Brunner, Hermine
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S23 - S24
  • [2] Neutropenia With Tocilizumab Treatment Is Not Associated With Increased Infection Risk In Patients With Systemic Juvenile Idiopathic Arthritis
    De Benedetti, Fabrizio
    Brunner, Hermine I.
    Baildam, Eileen M.
    Burgos-Vargas, Ruben
    Horneff, Gerd
    Huppertz, Hans-Iko
    Minden, Kirsten
    Myones, Barry L.
    Onel, Karen
    Wang, Jianmei
    Bharucha, Kamal N.
    Lovell, Daniel J.
    Martini, Alberto
    Ruperto, Nicolino
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S114 - S114
  • [3] PHARMACOKINETICS (PK) AND PHARMACODYNAMICS (PD) OF TOCILIZUMAB (TCZ) IN SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (sJIA).
    Zhang, X.
    Morcos, P. N.
    De Benedetti, F.
    Brunner, H.
    Ruperto, N.
    Schaefer, F.
    Roseti, S.
    Kenwright, A.
    Martini, A.
    Lovell, D.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 : S36 - S36
  • [4] Neutropenia With Tocilizumab Treatment Is Not Associated With Increased Infection Risk in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis
    De Benedetti, Fabrizio
    Rubio-Perez, Nadina
    Salazar, Carolina Duarte
    Goodman, Steven
    Job-Deslandre, Chantal
    Joos, Rik
    Kone-Paut, Isabelle
    Minden, Kirsten
    Onel, Karen
    Porter-Brown, Benjamin
    Bharucha, Kamal
    Wang, Jianmei
    Martini, Alberto
    Lovell, Daniel J.
    Brunner, Hermine I.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S67 - S68
  • [5] Neutropenia During Tocilizumab Treatment Is Not Associated with Infection Risk in Systemic or Polyarticular-course Juvenile Idiopathic Arthritis
    Pardeo, Manuela
    Wang, Jianmei
    Ruperto, Nicolino
    Alexeeva, Ekaterina
    Chasnyk, Vyacheslav
    Schneider, Rayfel
    Horneff, Gerd
    Huppertz, Hans-Iko
    Minden, Kirsten
    Onel, Karen
    Zemel, Lawrence
    Martin, Alan
    Kone-Paut, Isabelle
    Siamopoulou-Mavridou, Antigoni
    Silva, Clovis A.
    Porter-Brown, Benjamin
    Bharucha, Kamal N.
    Brunner, Hermine, I
    De Benedetti, Fabrizio
    [J]. JOURNAL OF RHEUMATOLOGY, 2019, 46 (09) : 1117 - 1126
  • [6] Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (sJIA): TENDER 52-week data
    Fabrizio De Benedetti
    Hermine Brunner
    Nicola Ruperto
    R Cuttica
    Clara Malattia
    Rayfel Schneider
    Patricia Woo
    Despina Eleftheriou
    Eileen Baildam
    Ruben Burgos-Vargas
    Pavla Dolezalova
    Stella M Garay
    Rik Joos
    Nico Wulffraat
    Zbyszek Zuber
    Francesco Zulian
    Carine Wouters
    Ricardo M Xavier
    Lawrence Zemel
    Stephen Wright
    Andy Kenwright
    Alberto Martini
    Daniel Lovell
    [J]. Pediatric Rheumatology, 10 (Suppl 1)
  • [7] Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (SJIA): tender 52-week data
    F De Benedetti
    H Brunner
    N Ruperto
    R Schneider
    P Woo
    R Burgos-Vargas
    P Dolezalova
    R Joos
    N Wulffraat
    Z Zuber
    F Zulian
    R Allen
    D Brown
    J Chaitow
    M Pardeo
    G Espada
    B Flato
    V Gerloni
    G Horneff
    S Wright
    A Kenwright
    D Lovell
    A Martini
    [J]. Pediatric Rheumatology, 9 (Suppl 1)
  • [8] PReS-FINAL-2134: Assessment of radiographic progression in patients (pts) with systemic juvenile idiopathic arthritis (sjia) treated with tocilizumab (TCZ): 2-year results from the tender trial
    C Malattia
    N Ruperto
    E Palmisani
    S Pederzoli
    A Pistorio
    HI Brunner
    R Cuttica
    I Calvo
    SM Garay
    D Eleftheriou
    C Wouters
    J Wang
    C Devlin
    D Lovell
    A Martini
    F De Benedetti
    A Ravelli
    [J]. Pediatric Rheumatology, 11 (Suppl 2)
  • [9] Tocilizumab therapy improves abnormal mitochondrial function in patients with systemic juvenile idiopathic arthritis (sJIA)
    Mima, Toru
    Aoki, Chieko
    Adachi, Yasuo
    Suguno, Hidehiko
    Lee, Hooiming
    Yoshio-Hoshino, Naoko
    Imagawa, Tomoyuki
    Mori, Masaaki
    Tomiita, Minako
    Iwata, Naomi
    Murata, Takuji
    Miyoshi, Mari
    Takei, Syuji
    Aihara, Yukoh
    Yokota, Shumpei
    Matsubara, Kenichi
    Nishimoto, Norihiro
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S497 - S498
  • [10] PReS-FINAL-2159: Tocilizumab (TCZ) dosing in juvenile idiopathic arthritis (JIA): optimising for different JIA type and body weight patients
    P Lu
    J Hsu
    C Keane
    S Fettner
    J Wang
    N Ruperto
    O Harari
    HI Brunner
    F De Benedetti
    [J]. Pediatric Rheumatology, 11 (Suppl 2)
12345